UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy

FEBS letters, 2010-06, Vol.584 (12), p.2699-2706

2010

Volltextzugriff (PDF)

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer

PloS one, 2017-03, Vol.12 (3), p.e0172911-e0172911

2017

Volltextzugriff (PDF)

Serum HER‐2/neu and relative resistance to trastuzumab‐based therapy in patients with metastatic breast cancer

Cancer, 2008-09, Vol.113 (6), p.1294-1301

2008

Volltextzugriff (PDF)

Coupled pre‐mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli

Molecular systems biology, 2011-09, Vol.7 (1), p.529-n/a

2011

Volltextzugriff (PDF)

Lymphoepithelial Carcinoma of Larynx and Hypopharynx: A Rare Clinicopathological Entity

Cancers, 2020-09, Vol.12 (9), p.2431

2020

Volltextzugriff (PDF)

Reply to B. Abderrahman and V. C. Jordan

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2676-2677

2016

Volltextzugriff (PDF)

Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy

PloS one, 2012-12, Vol.7 (12), p.e51379-e51379

2012

Volltextzugriff (PDF)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

Breast cancer research and treatment, 2013-08, Vol.141 (1), p.43-53

2013

Volltextzugriff (PDF)

Long-term Survival After Salvage Surgery for a Giant Primary Rib Osteosarcoma

The Annals of thoracic surgery, 2021-01, Vol.111 (1), p.e45-e47

2021

Volltextzugriff (PDF)

Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer

Critical reviews in oncology/hematology, 2012-12, Vol.84 (Suppl 1), p.e49-e57

2012

Volltextzugriff (PDF)

Open-Wedge Osteotomy Using an Internal Plate Fixator in Patients With Medial-Compartment Gonarthritis and Varus Malalignment: 3-Year Results With Regard to Preoperative Arthroscopic and Radiographic Findings

Arthroscopy, 2010-12, Vol.26 (12), p.1607-1616

2010

Volltextzugriff (PDF)

Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

Clinical cancer research, 2010-08, Vol.16 (16), p.4226-4235

2010

Volltextzugriff (PDF)

Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes

BMC bioinformatics, 2010-07, Vol.11 (1), p.400-400, Article 400

2010

Volltextzugriff (PDF)

Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration

PloS one, 2013-12, Vol.8 (12), p.e80566-e80566

2013

Volltextzugriff (PDF)

Aromatase Inhibitor Therapy As Effective Rescue in a Patient With Tamoxifen-Refractory Metastatic Granulosa Cell Tumor of the Ovary

Journal of clinical oncology, 2016-02, Vol.34 (5), p.e31-e33

2016

Volltextzugriff (PDF)

High‐level ERBB2 gene amplification is associated with a particularly short time‐to‐metastasis, but results in a high rate of complete response once trastuzumab‐based therapy is offered in the metastatic setting

International journal of cancer, 2014-07, Vol.135 (1), p.224-231

2014

Volltextzugriff (PDF)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma

BMC cancer, 2014-12, Vol.14 (1), p.981-981, Article 981

2014

Volltextzugriff (PDF)

Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data

International journal of gynecological cancer, 2018-07, Vol.28 (6), p.1196-1202

2018

Volltextzugriff (PDF)

Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Clinical cancer research, 2004-03, Vol.10 (5), p.1618-1624

2004

Volltextzugriff (PDF)

Coordinated Pulses of mRNA and of Protein Translation or Degradation Produce EGF-Induced Protein Bursts

Cell reports (Cambridge), 2017-03, Vol.18 (13), p.3129-3142

2017

Volltextzugriff (PDF)

Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies

Biochimica et biophysica acta, 2008-12, Vol.1786 (2), p.105-113

2008

Volltextzugriff (PDF)

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer

Frontiers in cardiovascular medicine, 2021-10, Vol.8, p.725903-725903

2021

Volltextzugriff (PDF)

Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab

Cancer, 2010-11, Vol.116 (22), p.5168-5178

2010

Volltextzugriff (PDF)

Signet Ring Cell Carcinoma of the Lung: A Diagnostic Pitfall in Pregnancy

Case reports in obstetrics and gynecology, 2019, Vol.2019 (2019), p.1-8

2019

Volltextzugriff (PDF)

Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression

EMBO molecular medicine, 2015-03, Vol.7 (3), p.299-314

2015

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(138)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(141)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer

Serum HER‐2/neu and relative resistance to trastuzumab‐based therapy in patients with metastatic breast cancer

Coupled pre‐mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli

Lymphoepithelial Carcinoma of Larynx and Hypopharynx: A Rare Clinicopathological Entity

Reply to B. Abderrahman and V. C. Jordan

Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

Long-term Survival After Salvage Surgery for a Giant Primary Rib Osteosarcoma

Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer

Open-Wedge Osteotomy Using an Internal Plate Fixator in Patients With Medial-Compartment Gonarthritis and Varus Malalignment: 3-Year Results With Regard to Preoperative Arthroscopic and Radiographic Findings

Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes

Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration

Aromatase Inhibitor Therapy As Effective Rescue in a Patient With Tamoxifen-Refractory Metastatic Granulosa Cell Tumor of the Ovary

High‐level ERBB2 gene amplification is associated with a particularly short time‐to‐metastasis, but results in a high rate of complete response once trastuzumab‐based therapy is offered in the metastatic setting

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma

Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data

Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Coordinated Pulses of mRNA and of Protein Translation or Degradation Produce EGF-Induced Protein Bursts

Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer

Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab

Signet Ring Cell Carcinoma of the Lung: A Diagnostic Pitfall in Pregnancy

Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression

Suchergebnisse filtern